Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
+5.1%/yr
Long-term compound
Percentile
P82
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 13.69% |
| Q3 2025 | 8.15% |
| Q2 2025 | -6.49% |
| Q1 2025 | 6.45% |
| Q4 2024 | -2.58% |
| Q3 2024 | 7.54% |
| Q2 2024 | 6.95% |
| Q1 2024 | 6.25% |
| Q4 2023 | -8.42% |
| Q3 2023 | 4.54% |
| Q2 2023 | 6.53% |
| Q1 2023 | -7.71% |
| Q4 2022 | -1.24% |
| Q3 2022 | 4.67% |
| Q2 2022 | 53.27% |
| Q1 2022 | 5.24% |
| Q4 2021 | -6.83% |
| Q3 2021 | 15.55% |
| Q2 2021 | 6.13% |
| Q1 2021 | 66.67% |
| Q4 2020 | 10.67% |
| Q3 2020 | -0.56% |
| Q2 2020 | 7.04% |
| Q1 2020 | -12.99% |
| Q4 2019 | 52.79% |
| Q3 2019 | -11.36% |
| Q2 2019 | -2.63% |
| Q1 2019 | -2.53% |
| Q4 2018 | -0.96% |
| Q3 2018 | -6.37% |
| Q2 2018 | -4.18% |
| Q1 2018 | -4.71% |
| Q4 2017 | 45.58% |
| Q3 2017 | 3.59% |
| Q2 2017 | 52.04% |
| Q1 2017 | -13.29% |
| Q4 2016 | -7.43% |
| Q3 2016 | -4.60% |
| Q2 2016 | -4.20% |
| Q1 2016 | 70.03% |